Early mortality of brain cancer patients and its connection to cytomegalovirus reactivation during radiochemotherapy.

CONCLUSIONS: For brain cancer patients, HCMV-reactivation after the start of radiochemotherapy is a frequent risk for cognitively detrimental but treatable encephalopathy and premature death. Routinely performed HCMV-diagnostics, assessing basophil counts and study-based anti-viral regimens are necessary to combat this hidden threat.
PMID: 32060103 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - February 13, 2020 Category: Cancer & Oncology Authors: Goerig NL, Frey B, Korn K, Fleckenstein B, Überla K, Schmidt MA, Dörfler A, Engelhorn T, Eyüpoglu I, Rühle PF, Putz F, Semrau S, Gaipl US, Fietkau R Tags: Clin Cancer Res Source Type: research